Exercise During Chemotherapy in Older Women With Stage I-III Breast Cancer
NCT05025059 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2026-03-05
Summary
This clinical trial evaluates the feasibility of exercise during chemotherapy in older women with stage I-III breast cancer. Previous studies have reported that exercise may reduce the chemotherapy-toxicity risk. This trial may help researchers learn if engaging in a physical activity program is feasible in patients receiving chemotherapy for breast cancer.
Conditions
- Anatomic Stage I Breast Cancer AJCC v8
- Anatomic Stage IA Breast Cancer AJCC v8
- Anatomic Stage IB Breast Cancer AJCC v8
- Anatomic Stage II Breast Cancer AJCC v8
- Anatomic Stage IIA Breast Cancer AJCC v8
- Anatomic Stage IIB Breast Cancer AJCC v8
- Anatomic Stage III Breast Cancer AJCC v8
- Anatomic Stage IIIA Breast Cancer AJCC v8
- Anatomic Stage IIIB Breast Cancer AJCC v8
- Anatomic Stage IIIC Breast Cancer AJCC v8
- Prognostic Stage I Breast Cancer AJCC v8
- Prognostic Stage IA Breast Cancer AJCC v8
- Prognostic Stage IB Breast Cancer AJCC v8
- Prognostic Stage II Breast Cancer AJCC v8
- Prognostic Stage IIA Breast Cancer AJCC v8
- Prognostic Stage IIB Breast Cancer AJCC v8
- Prognostic Stage III Breast Cancer AJCC v8
- Prognostic Stage IIIA Breast Cancer AJCC v8
- Prognostic Stage IIIB Breast Cancer AJCC v8
- Prognostic Stage IIIC Breast Cancer AJCC v8
Interventions
- PROCEDURE
-
Discussion
Participate in coaching sessions
- OTHER
-
Exercise Intervention
Perform walking exercise
- OTHER
-
Exercise Intervention
Perform strength exercises
- OTHER
-
Informational Intervention
Receive WWE workbook and Growing Stronger Strength Training Program instruction manual
- OTHER
-
Informational Intervention
Maintain exercise log
- OTHER
-
Medical Device Usage and Evaluation
Wear fitness tracker
- OTHER
-
Quality-of-Life Assessment
Complete questionnaires
- OTHER
-
Questionnaire Administration
Complete questionnaires
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Meghan Karuturi · M.D. Anderson Cancer Center
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 65 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-03
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- United States
Study Locations
More Related Trials
-
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer
NCT02598557 ·Status: COMPLETED ·Phase: PHASE2
-
Exercise Training in Postmenopausal Patients With Breast Cancer
NCT01384838 ·Status: COMPLETED ·Phase: NA
-
Identifying Decision Making Needs for Older Adult Women With Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy
NCT05049746 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Longitudinal Impact of Adjuvant Chemotherapy on Functional Status, Comorbidity and Quality of Life
NCT01030250 ·Status: ACTIVE_NOT_RECRUITING
-
Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors
NCT03953157 ·Status: COMPLETED ·Phase: NA
-
Geriatric Care Survivorship Intervention for Improving the Overall Health of Older Adults With Stage I-III Breast Cancer Who Have Completed Curative Treatment
NCT05928325 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Interactive Care Plan for the Monitoring of Symptoms and Recovery in Patients With Stage 0-III Breast Cancer
NCT04693338 ·Status: COMPLETED ·Phase: PHASE1
-
Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole
NCT00316836 ·Status: COMPLETED
-
Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy
NCT04379570 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
NCT00002582 ·Status: COMPLETED ·Phase: PHASE3
-
A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer
NCT04086875 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer
NCT00080613 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Effect of an Exercise Program in Breast Cancer Patients With Joint Pain While Taking Aromatase Inhibitors.
NCT02057536 ·Status: COMPLETED ·Phase: NA
-
Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer
NCT00002580 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Tamoxifen on Breast Density in Premenopausal Women With Breast Cancer or High Risk for Breast Cancer
NCT00086749 ·Status: COMPLETED
-
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
NCT00066690 ·Status: COMPLETED ·Phase: PHASE3
-
Activity Program During Aromatase Inhibitor Therapy
NCT03786198 ·Status: COMPLETED ·Phase: NA
-
Effects of Short-term Fasting on Tolerance to Chemotherapy
NCT01304251 ·Status: COMPLETED ·Phase: NA
-
Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer
NCT05253066 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer
NCT00031811 ·Status: COMPLETED ·Phase: NA
-
Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast Cancer
NCT01874184 ·Status: COMPLETED ·Phase: NA
-
Effect of a Clinical Nutrition Intervention Program in Breast Cancer Patients During Antineoplastic Treatment
NCT03625635 ·Status: UNKNOWN ·Phase: NA
-
Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer
NCT00002581 ·Status: COMPLETED ·Phase: PHASE3
-
Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer
NCT00002579 ·Status: COMPLETED ·Phase: PHASE3
-
Attenuating Cancer Treatment-related Toxicity in Oncology Patients With a Tailored Physical Exercise Program
NCT03787966 ·Status: COMPLETED ·Phase: NA